Patent Assignment
Reel/Frame 059214/0829
Merger
Recorded: 2022-03-09
Pages: 11
Assignor
CALIDI BIOTHERAPEUTICS, INC.
Executed: 2019-06-05
Assignee
CALIDI BIOTHERAPEUTICS, INC.
11011 NORTH TORREY PINES ROAD, SUITE 200, LA JOLLA, CALIFORNIA, 92037
Covered Property
(1)
Combination Immunotherapy Approach for Treatment of Cancer
Application:
17/689,643 →
Publication:
US US20220241388A1
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Mar 9, 2022
From: SZALAY, ALADAR; MINEV, BORIS
To: STEMIMMUNE, INCORPORATED
Reel/Frame 059214/0775 →
Change of Name
Mar 9, 2022
From: STEMIMMUNE, INC.
To: CALIDI BIOTHERAPEUTICS, INC.
Reel/Frame 059357/0545 →
Change of Name
May 1, 2024
From: CALIDI BIOTHERAPEUTICS, INC.
To: CALIDI BIOTHERAPEUTICS (NEVADA), INC.
Reel/Frame 067285/0965 →